Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period

ClinicalTrials.gov ID: NCT03116698

Public ClinicalTrials.gov record NCT03116698. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 5:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Study to Evaluate the Dose-Response Relationship of the Efficacy and Safety of Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Once or twice daily 12 week treatment in patients with Actinic Keratosis randomized to treatment in one of four arms.

Study identification

NCT ID
NCT03116698
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Enrollment
240 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 14, 2017 (Actual)
Primary completion
Nov 13, 2017 (Actual)
Completion
Jul 5, 2018 (Actual)
Last update posted
Apr 24, 2019

2017 – 2018

United States locations

U.S. sites
20
U.S. states
6
U.S. cities
17
Facility City State ZIP Site status
Investigator Site 3 Cerritos California 90703 —
Investigator Site 1 Fremont California 94538 —
Investigator Site 9 Palm Springs California 92262 —
Investigator Site 18 Santa Ana California 92701 —
Investigator Site 16 Boca Raton Florida 33486 —
Investigator Site 8 Lake City Florida 32055 —
Investigator Site 7 Miami Florida 33126 —
Investigator Site 19 Miami Florida 33162 —
Investigator Site 20 Miami Lakes Florida 33016 —
Investigator Site 17 Ormond Beach Florida 32174 —
Investigator Site 6 West Palm Beach Florida 33409 —
Investigator Site 13 Verona New Jersey 07044 —
Investigator Site 15 Stony Brook New York 11790 —
Investigator Site 14 Fort Washington Pennsylvania 19034 —
Investigator Site 10 Austin Texas 78660 —
Investigator Site 4 Houston Texas 77055 —
Investigator Site 5 Plano Texas 75024 —
Investigator Site 11 San Antonio Texas 78229 —
Investigator Site 2 San Antonio Texas 78229 —
Investigator Site 12 San Antonio Texas 78249 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03116698, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 24, 2019 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03116698 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →